What this study is
The purpose of this study is to help make a community led weight loss program known as Take Off Pounds Sensibly (TOPS) more relevant for breast cancer survivors.
This study is made up to two parts. The first part includes using focus groups to review current materials that the investigators plan to use in upcoming TOPS classes and provide feedback. Focus groups will be made up of women who are breast cancer survivors.
The second part includes taking the feedback received from these focus groups and use this feedback to tailor TOPS classes for breast cancer survivors.
This ClinicalTrials.gov record is specific to the second part of the study.
What's being tested
- TOPS Classes
Intervention · OTHER
Attend Dietician-Led Sessions
Study details
- Official title
- Planning Grant for Take Off Pounds Sensibly (TOPS) Classes for Breast Cancer Survivors
- Sponsor
- Duke University
- Conditions
- Breast Cancer · Weight Loss
- Enrolling
- 25 people
- Starts
- 2026-08-03
- Est. completion
- 2027-09-30
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 21 Years – 90 YearsSex FEMALEHealthy volunteers Not acceptedYou may qualify if
- Aim 2 Inclusion Criteria:; women diagnosed with breast cancer with BMI ≥ 25 kg/m2 after completion of primary therapy (surgery, radiation, adjuvant or neo-adjuvant chemotherapy). Aim 2 Exclusion Criteria:; Those whose oncology providers do not agree with their participation in a weight loss program; History of Type II Diabetes Mellitus; those participating in another weight loss program; those taking a weight loss medication; those without smart phones or internet connections or the ability to attend meetings via Zoom
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openDuke University
Durham, North Carolina, United States
- Nia S Mitchell, MD · Contact833-637-8839nia.s.mitchell@duke.edu
Recruiting
Study team
Sponsor
Duke University
Study ID Pro00116571
Principal investigator
Nia S Mitchell, MD
Duke University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.